Noxopharm Ltd Sustainability Reports
Noxopharm Limited is a clinical-stage drug development company focused on discovering and developing novel treatments for cancer and inflammation. The company develops drug pipeline products built upon its proprietary Sofra and Chroma technology platforms.
Sector: Manufacturing
Country: Australia
Exchange: Australian Securities Exchange
FIGI: BBG00D34SWR9
10 reports from 2016 to 2025
